These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9067566)

  • 21. [Treatment of rectocolic and gastric adenocarcinomas with 5-fluorouracil associated with high doses of folinic acid. Results of an experimental study].
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Delouche C; Brochon D; Fraioli JP; Jasmin C; Maral R; Mathe G
    Sem Hop; 1982 Sep; 58(33):1873-5. PubMed ID: 6293063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
    Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
    Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
    Scheithauer W; Kornek G; Marczell A; Salem G; Karner J; Kovats E; Burger D; Greiner R; Pidlich J; Schneeweiss B; Raderer M; Rosen H; Depisch D
    J Clin Oncol; 1997 Mar; 15(3):908-14. PubMed ID: 9060527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with 5-fluorouracil (5-FU) and high-dose folinic acid in solid tumors.
    Marini G; Zaniboni A; Gorni F; Marpicati P; Montini E; Simoncini E
    Drugs Exp Clin Res; 1987; 13(6):373-6. PubMed ID: 3498615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma.
    Hsue V; Wong CS; Moore M; Erlichman C; Cummings BJ; MacLeod M
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):445-50. PubMed ID: 8567347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
    Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
    Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Jasmin C; Maral R; Mathé G
    Cancer Treat Rep; 1982 Oct; 66(10):1803-7. PubMed ID: 6982099
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
    Loeffler TM; Hausamen TU
    J Infus Chemother; 1996; 6(3):137-40. PubMed ID: 9229325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer--preliminary results of a randomized trial.
    Steinke B; Günther E; Hirschmann WD; Sondern W; Koniczek KH; Wander HE; Natt F; Wagner T; Hinrichs HF; Werdier D
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):141-7. PubMed ID: 1557640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
    Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
    Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced colorectal cancer with high-dose intensity folinic acid and 5-fluorouracil plus supportive care.
    Petrioli R; Lorenzi M; Aquino A; Marsili S; Frediani B; Palazzuoli V; Marzocca G; Botta G; Tani F; De Martino A
    Eur J Cancer; 1995 Nov; 31A(12):2105-8. PubMed ID: 8562173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer.
    Colleoni M; Di Bartolomeo M; Di Leo A; Zilembo N; Carnaghi C; Pandolfi A; Rimassa L; Artale S; Bajetta E
    Eur J Cancer; 1995 Dec; 31A(13-14):2426-7. PubMed ID: 8652289
    [No Abstract]   [Full Text] [Related]  

  • 34. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
    Kerr DJ; McArdle CS; Ledermann J; Taylor I; Sherlock DJ; Schlag PM; Buckels J; Mayer D; Cain D; Stephens RJ; ;
    Lancet; 2003 Feb; 361(9355):368-73. PubMed ID: 12573372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I study of 5-fluorouracil, leucovorin and levamisole.
    Cleary JF; Arzoomanian R; Alberti D; Feierabend C; Storer B; Witt P; Carbone P; Wilding G
    Cancer Chemother Pharmacol; 1997; 39(4):300-6. PubMed ID: 9025770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
    J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.
    Petrioli R; Sabatino M; Roviello F; Marrelli D; Nastri G; Marsili S; Correale P; Pozzessere D; Messinese S; De Martino A; Tani F; Marzocca G; Lorenzi M; Civitelli S; Tanzini G; Pinto E; Francini G
    Hepatogastroenterology; 2005; 52(65):1626-30. PubMed ID: 16201130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].
    de Gramont A; Louvet C; André T; Tournigand C; Raymond E; Molitor JL; Krulik M
    Rev Med Interne; 1997; 18 Suppl 4():372s-378s. PubMed ID: 9365715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens.
    Bajetta E; Di Bartolomeo M; Somma L; Del Vecchio M; Artale S; Zunino F; Bignami P; Magnani E; Buzzoni R
    Eur J Cancer; 1997 Apr; 33(4):687-90. PubMed ID: 9274455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effect and characteristics of low dose leucovorin and high dose 5-FU therapy in patients with recurrent gastric cancer--a new method of biochemical modulation].
    Kajiyama Y; Tsurumaru M; Ono Y; Udagawa H; Watanabe G; Suzuki M; Matsuda M; Akiyama H
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1797-801. PubMed ID: 8379672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.